Hussein Ghamlouch

12PUBLICATIONS
54CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 27, 2026
Study of NSD2 using a dTAG system reveals its molecular mechanism and oncogenic implications in t(4;14) multiple myeloma.

Yubao Wang, Sanxiong Liu, Hussein Ghamlouch

|Jan 15, 2026
Tet2 deficiency promotes IgG1+ B-cell expansion and differentiation blockade through deregulation of the Nfkbia-c-Rel axis.

Hussein Ghamlouch, Michaël Degaud, Veronique Della-Valle

|May 07, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.

Dylan C Gagler, Hussein Ghamlouch, Di Zhang

|Jul 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.

Eileen M Boyle, Patrick Blaney, James H Stoeckle

|Dec 03, 2021
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer.

Hussein Ghamlouch, Eileen M Boyle, Patrick Blaney

|Oct 29, 2020
Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia.

Walaa Darwiche, Cathy Gomila, Hakim Ouled-Haddou

Pageof 2

Frequent Collaborators

4 joint publications

Yubao Wang

3 joint publications

Said Aoufouchi

3 joint publications

Patrick Blaney

3 joint publications

Brian A Walker